litlas
Log inCreate account

Davide Ruggero

Active 1998–2025

68
Papers
19,804
Citations
54
h-index
68
i10-index

Citations

Citations per year for Davide Ruggero1985: 1 citations1990: 1 citations1994: 1 citations1998: 1 citations1999: 19 citations2000: 35 citations2001: 43 citations2002: 40 citations2003: 44 citations2004: 88 citations2005: 69 citations2006: 128 citations2007: 142 citations2008: 144 citations2009: 152 citations2010: 223 citations2011: 260 citations2012: 257 citations2013: 306 citations2014: 354 citations2015: 358 citations2016: 328 citations2017: 334 citations2018: 295 citations2019: 795 citations2020: 999 citations2021: 886 citations2022: 616 citations2023: 490 citations2024: 700 citations2025: 334 citations2026: 22 citations1986–1989: no citations, so these years are not shown1991–1993: no citations, so these years are not shown1995–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,113 citing papers, 31.5% of this breakdownChina: 1,233 citing papers, 12.5% of this breakdownUnited Kingdom: 558 citing papers, 5.6% of this breakdownGermany: 491 citing papers, 5% of this breakdownCanada: 458 citing papers, 4.6% of this breakdownFrance: 403 citing papers, 4.1% of this breakdownItaly: 367 citing papers, 3.7% of this breakdownJapan: 297 citing papers, 3% of this breakdownSpain: 236 citing papers, 2.4% of this breakdownAustralia: 215 citing papers, 2.2% of this breakdownSwitzerland: 211 citing papers, 2.1% of this breakdownNetherlands: 173 citing papers, 1.8% of this breakdown
0%31.5%Other 21.5%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology62.9%
  • Medicine25.8%
  • Immunology and Microbiology5.5%
  • Neuroscience2.6%
  • Computer Science0.7%
  • Agricultural and Biological Sciences0.5%
  • Other2%

Topics

  • RNA modifications and cancer6.8%
  • RNA and protein synthesis mechanisms4.6%
  • RNA Research and Splicing4.2%
  • PI3K/AKT/mTOR signaling in cancer3.9%
  • Endoplasmic Reticulum Stress and Disease2.9%
  • Cancer Cells and Metastasis2.6%
  • Other75%

Coauthors

All papers

Open in search
  1. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

    Authors: Rosandra N. Kaplan, Rebecca D. Riba, Stergios Zacharoulis, Anna H. Bramley, Loı̈c Vincent, Carla Costa, Daniel D. MacDonald, David Jin, Koji Shido, Scott Kerns, Zhenping Zhu, Daniel J. Hicklin, Yan Wu, Jeffrey L. Port, Nasser K. Altorki, Elisa Port, Davide Ruggero, Sergey V. Shmelkov, Kristian K. Jensen, Shahin Rafii, David Lyden - Nature 2005 cited by 3,260

  2. The translational landscape of mTOR signalling steers cancer initiation and metastasis

    Authors: Andrew C. Hsieh, Yi Liu, Merritt P. Edlind, Nicholas T. Ingolia, Matthew R. Janes, Annie Sher, Evan Y. Shi, Craig R. Stumpf, Carly Christensen, Michael Bonham, Shunyou Wang, Pingda Ren, Michael Martin, Katti Jessen, Morris E. Feldman, Jonathan S. Weissman, Kevan M. Shokat, Christian Rommel, Davide Ruggero - Nature 2012 cited by 1,376

  3. Translation control of the immune checkpoint in cancer and its therapeutic targeting

    Authors: Yichen Xu, Mauro Poggio, Hyun Yong Jin, Zhen Shi, Craig M. Forester, Ying Wang, Craig R. Stumpf, Lingru Xue, Emily N. Devericks, Lomon So, Hao G. Nguyen, Alice Griselin, John D. Gordan, Sarah E. Umetsu, Siegfried Reich, Stephen T. Worland, Saurabh Asthana, Maria Barna, Kevin R. Webster, John T. Cunningham, Davide Ruggero - Nature Medicine 2019 cited by 265

  4. Translational Control in Cancer

    Authors: Nathaniel Robichaud, Nahum Sonenberg, Davide Ruggero, Robert J. Schneider - Cold Spring Harbor Perspectives in Biology 2018 cited by 303

  5. ATF4 couples MYC-dependent translational activity to bioenergetic demands during tumour progression

    Authors: Feven Tameire, Ioannis I. Verginadis, Nektaria Maria Leli, Christine Polte, Crystal S. Conn, Rani Ojha, Carlo Salas Salinas, Frank Chinga, Alexandra M. Monroy, Weixuan Fu, Zhiping Wang, Andrew V. Kossenkov, Jiangbin Ye, Ravi K. Amaravadi, Zoya Ignatova, Serge Y. Fuchs, J. Alan Diehl, Davide Ruggero, Constantinos Koumenis - Nature Cell Biology 2019 cited by 302

  6. Oncogenic KRAS Regulates Amino Acid Homeostasis and Asparagine Biosynthesis via ATF4 and Alters Sensitivity to L-Asparaginase

    Authors: Dana M. Gwinn, Alex G. Lee, Marcela Briones-Martín-del-Campo, Crystal S. Conn, David R. Simpson, Anna I. Scott, Anthony Le, Tina M. Cowan, Davide Ruggero, E. Alejandro Sweet‐Cordero - Cancer Cell 2018 cited by 228

  7. IRE1α Cleaves Select microRNAs During ER Stress to Derepress Translation of Proapoptotic Caspase-2

    Authors: John-Paul Upton, Likun Wang, Dan Han, Eric S. Wang, Noelle E. Huskey, Lionel Lim, Morgan Truitt, Michael T. McManus, Davide Ruggero, Andrei Goga, Feroz R. Papa, Scott A. Oakes - Science 2012 cited by 643

  8. ERα is an RNA-binding protein sustaining tumor cell survival and drug resistance

    Authors: Yichen Xu, Peiwei Huangyang, Ying Wang, Lingru Xue, Emily N. Devericks, Hao G. Nguyen, Xiuyan Yu, Juan A. Osés-Prieto, Alma L. Burlingame, Sohit Miglani, Hani Goodarzi, Davide Ruggero - Cell 2021 cited by 175

  9. rRNA Pseudouridylation Defects Affect Ribosomal Ligand Binding and Translational Fidelity from Yeast to Human Cells

    Authors: Karen D. Jack, Cristian Bellodi, Dori M. Landry, Rachel O. Niederer, Arturas Meškauskas, Sharmishtha Musalgaonkar, Noam E. Kopmar, Olya Krasnykh, Alison M. Dean, Sunnie R. Thompson, Davide Ruggero, Jonathan D. Dinman - Molecular Cell 2011 cited by 333

  10. New frontiers in translational control of the cancer genome

    Authors: Morgan Truitt, Davide Ruggero - Nature reviews. Cancer 2016 cited by 399

  11. Differential Requirements for eIF4E Dose in Normal Development and Cancer

    Authors: Morgan Truitt, Crystal S. Conn, Zhen Shi, Xiaming Pang, Taku A. Tokuyasu, Alison Coady, Youngho Seo, Maria Barna, Davide Ruggero - Cell 2015 cited by 399

  12. Protein synthesis control in cancer: selectivity and therapeutic targeting

    Authors: Joanna Kovalski, Duygu Kuzuoğlu‐Öztürk, Davide Ruggero - The EMBO Journal 2022 cited by 122

  13. Erratum: New frontiers in translational control of the cancer genome

    Authors: Morgan Truitt, Davide Ruggero - Nature reviews. Cancer 2017 cited by 313

  14. ER stress–mediated autophagy promotes Myc-dependent transformation and tumor growth

    Authors: Lori S. Hart, John T. Cunningham, Tatini Datta, Souvik Dey, Feven Tameire, Stacey L. Lehman, Bo Qiu, Haiyan Zhang, George J. Cerniglia, Meixia Bi, Yan Li, Yan Gao, Huayi Liu, Changhong Li, Amit Maity, Andrei Thomas‐Tikhonenko, Alexander E. Perl, Albert C. Koong, Serge Y. Fuchs, J. Alan Diehl, Ian G. Mills, Davide Ruggero, Constantinos Koumenis - Journal of Clinical Investigation 2012 cited by 446

  15. Targeting the eIF4F Translation Initiation Complex: A Critical Nexus for Cancer Development

    Authors: Jerry Pelletier, Jeremy R. Graff, Davide Ruggero, Nahum Sonenberg - Cancer Research 2015 cited by 370

  16. Protein and Nucleotide Biosynthesis Are Coupled by a Single Rate-Limiting Enzyme, PRPS2, to Drive Cancer

    Authors: John T. Cunningham, Melissa V. Moreno, Alessia Lodi, Sabrina M. Ronen, Davide Ruggero - Cell 2014 cited by 270

  17. Development of a stress response therapy targeting aggressive prostate cancer

    Authors: Hao G. Nguyen, Crystal S. Conn, Yae Kye, Lingru Xue, Craig M. Forester, Janet E. Cowan, Andrew C. Hsieh, John T. Cunningham, Charles Truillet, Feven Tameire, Michael J. Evans, Christopher P. Evans, Joy C. Yang, Byron Hann, Constantinos Koumenis, Peter Walter, Peter R. Carroll, Davide Ruggero - Science Translational Medicine 2018 cited by 173

  18. Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

    Authors: Morris E. Feldman, Beth Apsel, Aino Uotila, Robbie Loewith, Zachary A. Knight, Davide Ruggero, Kevan M. Shokat - PLoS Biology 2009 cited by 1,077

  19. A single H/ACA small nucleolar RNA mediates tumor suppression downstream of oncogenic RAS

    Authors: Mary McMahon, Adrian Contreras, Mikael Holm, Tamayo Uechi, Craig M. Forester, Xiaming Pang, Cody B. Jackson, Meredith Calvert, Bin Chen, David A. Quigley, John M. Luk, R. K. Kelley, John D. Gordan, Ryan M. Gill, Scott C. Blanchard, Davide Ruggero - eLife 2019 cited by 142

  20. Myc and mTOR converge on a common node in protein synthesis control that confers synthetic lethality in Myc-driven cancers

    Authors: Michael Pourdehnad, Morgan Truitt, Imran Siddiqi, Gregory S. Ducker, Kevan M. Shokat, Davide Ruggero - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 296

  21. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency

    Authors: Maria Barna, Aya D. Pusic, Ornella Zollo, Maria Da Costa, Nadya Kondrashov, Eduardo Magalhães Rego, Pulivarthi H. Rao, Davide Ruggero - Nature 2008 cited by 427

  22. Autism-related deficits via dysregulated eIF4E-dependent translational control

    Authors: Christos G. Gkogkas, Arkady Khoutorsky, Israeli Ran, Emmanouil Rampakakis, Tatiana Nevarko, D. Weatherill, Cristina Vasuta, Stephanie S. Yee, Morgan Truitt, Paul Dallaire, François Major, Paul Lasko, Davide Ruggero, Karim Nader, Jean‐Claude Lacaille, Nahum Sonenberg - Nature 2012 cited by 531

  23. Impaired Control of IRES-Mediated Translation in X-Linked Dyskeratosis Congenita

    Authors: Andrew Yoon, Guang Peng, Yves Brandenburg, Ornella Zollo, Wei Xu, Eduardo Magalhães Rego, Davide Ruggero - Science 2006 cited by 420

  24. Evolutionarily divergent mTOR remodels translatome for tissue regeneration

    Authors: Olena Zhulyn, Hannah D. Rosenblatt, Leila Shokat, Shizhong Dai, Duygu Kuzuoğlu‐Öztürk, Zijian Zhang, Davide Ruggero, Kevan M. Shokat, Maria Barna - Nature 2023 cited by 69